O. D. Ortega-hernandez, N. Bassi, and Y. Shoenfeld, The long pentraxin 3 and its role in autoimmunity. Seminars in arthritis and rheumatism, vol.39, pp.38-54, 2009.

J. F. Augusto, C. Onno, and S. Blanchard, Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus, Rheumatology, vol.48, issue.4, pp.442-446, 2009.

A. Simon, J. F. Subra, and P. Guilpain, Detection of Anti-Pentraxin-3

, Autoantibodies in ANCA-Associated Vasculitis, PloS one, vol.2016, issue.1, p.147091

L. Deban, S. Jaillon, and C. Garlanda, Pentraxins in innate immunity: lessons from PTX3. Cell and tissue research, vol.343, pp.237-286, 2011.

A. J. Szalai, F. W. Van-ginkel, and Y. Wang, Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component, Journal of immunology, vol.165, issue.2, pp.1030-1035, 2000.

C. Garlanda, B. Bottazzi, and A. Bastone, Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility, Annual review of immunology, vol.23, pp.337-66, 2005.

M. B. Pepys and G. M. Hirschfield, C-reactive protein: a critical update, The Journal of clinical investigation, vol.111, issue.12, pp.1805-1817, 2003.

R. Latini, A. P. Maggioni, and G. Peri, Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction, Circulation, vol.110, issue.16, pp.2349-54, 2004.

B. Muller, G. Peri, and A. Doni, Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients, Critical care medicine, vol.29, issue.7, pp.1404-1411, 2001.

S. Jaillon, G. Peri, and Y. Delneste, The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. The Journal of experimental medicine, vol.204, pp.793-804, 2007.

K. Kessenbrock, M. Krumbholz, and U. Schonermarck, Netting neutrophils in autoimmune small-vessel vasculitis, Nature medicine, vol.15, issue.6, pp.623-628, 2009.

C. Mold, C. P. Rodgers, and R. L. Kaplan, Binding of human C-reactive protein to bacteria, Infection and immunity, vol.38, issue.1, pp.392-397, 1982.

J. N. Weiser, N. Pan, and K. L. Mcgowan, Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein, The Journal of experimental medicine, vol.187, issue.4, pp.631-671, 1998.

M. Noursadeghi, M. C. Bickerstaff, and J. R. Gallimore, Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen, Proceedings of the National Academy of Sciences of the United States of America, vol.97, pp.14584-14593, 2000.

A. J. Szalai, J. L. Vancott, and J. R. Mcghee, Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice, Infection and immunity, vol.68, issue.10, pp.5652-5658, 2000.

M. Lech, C. Rommele, and O. P. Kulkarni, Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus, PloS one, vol.6, issue.5, p.20118, 2011.

Z. Szondy, E. Garabuczi, and G. Joos, Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications, Frontiers in immunology, vol.5, p.354, 2014.

M. Mihlan, S. Stippa, and M. Jozsi, Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell death and differentiation, vol.16, pp.1630-1670, 2009.

A. P. Van-rossum, F. Fazzini, and P. C. Limburg, The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages, Arthritis and rheumatism, vol.50, issue.8, pp.2667-74, 2004.

W. Rodriguez, C. Mold, and L. L. Marnell, Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein, Arthritis and rheumatism, vol.54, issue.1, pp.325-360, 2006.

A. J. Szalai, C-reactive protein (CRP) and autoimmune disease: facts and conjectures, Clinical & developmental immunology, vol.11, issue.3-4, pp.221-227, 2004.

J. D. Gillmore, W. L. Hutchinson, and J. Herbert, Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology, vol.112, pp.255-64, 2004.

N. Firooz, D. A. Albert, and D. J. Wallace, High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus, vol.20, pp.588-97, 2011.

F. A. Robey, K. D. Jones, and A. D. Steinberg, C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. The Journal of experimental medicine, vol.161, pp.1344-56, 1985.

S. A. Bell, H. Faust, and A. Schmid, Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases, Clinical and experimental immunology, vol.113, issue.3, pp.327-359, 1998.

S. U. Eisenhardt, J. R. Thiele, and H. Bannasch, C-reactive protein: how conformational changes influence inflammatory properties, Cell cycle, vol.8, issue.23, pp.3885-92, 2009.

Y. Shoenfeld, M. Szyper-kravitz, and T. Witte, Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus, Annals of the New York Academy of Sciences, pp.227-266, 1108.

C. Sjowall, A. A. Bengtsson, and G. Sturfelt, Anti-CRP autoantibody levels correlate with disease activity in systemic lupus erythematosus. Seminars in arthritis and rheumatism, vol.35, p.65, 2005.

M. A. Figueredo, A. Rodriguez, and M. Ruiz-yague, Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome, The Journal of rheumatology, vol.33, issue.10, pp.1980-1986, 2006.

C. Sjowall, A. Zickert, and T. Skogh, Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis, Arthritis research & therapy, vol.11, issue.6, p.188, 2009.

Y. Tan, F. Yu, and H. Yang, Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions, Human immunology, vol.69, issue.12, pp.840-844, 2008.

Y. Tan, F. Yu, and Z. Qu, Modified C-reactive protein might be a target autoantigen of TINU syndrome, Clinical journal of the American Society of Nephrology : CJASN, vol.6, issue.1, pp.93-100, 2011.

G. Zandman-goddard, M. Blank, and P. Langevitz, Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Annals of the rheumatic diseases, vol.64, pp.1698-702, 2005.

N. Bassi, A. Ghirardello, and M. Blank, IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus, Annals of the rheumatic diseases, vol.2010, issue.9, pp.1704-1714

C. Beauvillain, Y. Delneste, and G. Renier, Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them?, Clinical reviews in allergy & immunology, vol.35, pp.47-58, 2008.

J. C. Jennette, R. J. Falk, and P. Hu, Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annual review of pathology, vol.8, pp.139-60, 2013.

A. J. Roth, J. D. Ooi, and J. J. Hess, Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis, The Journal of clinical investigation, vol.123, issue.4, pp.1773-83, 2013.

J. Sayegh, C. Poli, and A. Chevailler, Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCAassociated vasculitis. Internal and emergency medicine, 2014.